Astellas Pharma Inc.;TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz
发明人:
Ugur Sahin,Ozlem Tureci,Rita Mitnacht-Kraus,Stefan Woll,Stefan Jacobs,Cornelia Heinz
申请号：
US16401931
公开号：
US20190298803A1
申请日:
2019.05.02
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as pancreatic cancer and metastases thereof.
